cbdMD, Inc.
YCBD
$0.68
-$0.0249-3.53%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.00% | -7.12% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.00% | -7.12% | |||
| Cost of Revenue | -0.80% | 4.51% | |||
| Gross Profit | -4.34% | -12.97% | |||
| SG&A Expenses | 3.40% | 4.89% | |||
| Depreciation & Amortization | -1.99% | -4.06% | |||
| Other Operating Expenses | 143.44% | -56.72% | |||
| Total Operating Expenses | 5.28% | 0.68% | |||
| Operating Income | -86.23% | -462.92% | |||
| Income Before Tax | -86.21% | -3,284.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.21% | -3,284.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.21% | -3,284.11% | |||
| EBIT | -86.23% | -462.92% | |||
| EBITDA | -212.41% | -194.43% | |||
| EPS Basic | 88.83% | -9.88% | |||
| Normalized Basic EPS | 74.79% | -367.03% | |||
| EPS Diluted | 88.83% | -9.88% | |||
| Normalized Diluted EPS | 74.79% | -367.03% | |||
| Average Basic Shares Outstanding | 642.99% | 36.80% | |||
| Average Diluted Shares Outstanding | 642.99% | 36.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||